腹壁疝修补术后十年结局:呼吁美国加强上市后监测
该单中心回顾性纵向研究纳入2009-2019年645例腹壁疝修补患者,比较补片与非补片修补的10年并发症与复发率。中位随访2098天,10年无疝复发再手术生存概率85.26%,无急诊手术主要并发症生存概率94.44%,无非复发干预生存概率78.11%。作者认为腹壁疝可发展为慢性疾病,应加强手术方式及补片位置与类型的上市后监测。
要点
- 腹壁疝修补术后10年无复发再手术生存概率为85.26%
- 10年无急诊手术主要并发症生存概率为94.44%
- 腹壁疝可发展为需长期干预的慢性疾病
核心结论
- 高比例患者在接受腹壁疝修补术后出现需干预的远期复发和并发症,腹壁疝对许多患者而言成为慢性疾病。
研究设计与样本
- 单中心回顾性纵向研究,纳入2009-2019年接受补片或非补片腹壁疝修补的患者645例,平均年龄52.51±13.57岁,女性占50.70%。
- 通过电子病历收集社会人口学、临床和术中资料,以及早期(≤30天)和远期(>30天)术后并发症,远期并发症随访长达十年。
主要发现
- 中位随访2098天(四分位距1320-2806),短期手术部位感染率4.81%,手术部位事件率15.04%,其他并发症率13.64%。
- 10年无疝复发再手术(HRR)生存概率85.26%,无急诊手术主要并发症(MCES)生存概率94.44%,无非复发干预(NRPI)生存概率78.11%。
- 手术类型包括57.36%切口疝、37.21%非切口脐疝、8.22%非切口上腹疝、3.88%造口旁疝、0.93%腹直肌分离和0.47%半月线疝。
- 手术入路包括开放383例、腹腔镜267例、机器人21例;81.55%行筋膜关闭,66.2%使用补片。
临床怎么用
- 腹壁疝修补术后应关注长期复发和需干预的并发症,对患者进行长期随访。
- 需加强手术方式及补片位置与类型的上市后监测,以优化 outcomes。
局限性
- 单中心回顾性研究,可能存在选择偏倚和资料完整性限制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: We sought to identify the 10-year complication and recurrence rates and associated sociodemographic and operative characteristics associated with non-mesh versus mesh-based ventral hernia repairs (VHRs). METHODS: This was an IRB-approved (2020H0317) retrospective longitudinal study of patients undergoing mesh or non-mesh VHR from 2009-2019 at a single tertiary-care institution. The electronic medical record was used to collect sociodemographic, clinical, and intraoperative details, and early (≤ 30 days) and long-term (> 30-day) postoperative complications. Up to ten-year follow-up was obtained for long-term complications, categorized as: hernia recurrence reoperation (HRR), major complications requiring emergency surgery (MCES) (defined as non-elective operations related to the abdominal wall), and non-recurrence procedural intervention (NRPI) (defined as any procedures related to the abdominal wall, bowel, or mesh). Kaplan-Meier survival curves were obtained for each long-term complication. RESULTS: Of the 645 patients identified, the mean age at index operation was 52.51 ± 13.57 years with 50.70% female. Of the index operations, 21.24% were for a recurrence. Procedure categories included: 57.36% incisional, 37.21% non-incisional umbilical, 8.22% non-incisional epigastric, 3.88% parastomal, 0.93% diastasis recti, and 0.47% Spigelian hernias. Operative approaches included open (n = 383), laparoscopic (n = 267), and robotic (n = 21). Fascial closure (81.55%) and mesh use (66.2%) were performed in the majority of cases. Median follow-up time was 2098 days (interquartile range 1320-2806). The rate of short-term complications was 4.81% for surgical site infections, 15.04% for surgical site occurrences, and 13.64% for other complications. At 10 years, the HRR-free survival probability was 85.26%, MCES-free survival probability was 94.44%, and NRPI-free survival probability was 78.11%. CONCLUSIONS: A high proportion of patients experienced long-term recurrence and complications requiring intervention after index VHR. For many patients, a ventral hernia develops into a chronic medical condition. Improved efforts at post-market surveillance of operative approaches and mesh location and type should be undertaken to help optimize outcomes.
引用
- Kenawy DM, Underhill JM, Jacobs AG, et al. Ten-year outcomes following ventral hernia repair: making the case for better post-market surveillance in the USA. Surg Endosc. 2022. PMID: 36348168. doi:10.1007/s00464-022-09725-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。